- Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity. Journal of Controlled Release. 2017 Academic Article GET IT
Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.
Arteriosclerosis, Thrombosis, and Vascular Biology.
Times cited: 39